Since the mTOR inhibitor temsirolimus (Torisel or CCI-779) has efficacy in RCC [23] and promotes autophagy [31], [32], we assessed the functional consequences of coordinate autophagy inhibition with CQ in human RCC cell lines. The gene discussed is MTOR; the disease is renal cell carcinoma.